Stock Of The Day: Where Will The Eli Lilly Rally End?

Shares of Eli Lilly and Company LLY are trading higher on Wednesday. The company said that its Zepbound drug was more effective in helping adults with obesity lose weight than Novo Nordisk A/S's NVO Wegovy. It cited data from a phase 3b trial. But the rally may be short-lived. This is why Eli Lilly is our Stock of the Day. The company said that using Zepbound led to a 20.2% weight loss. This was significantly better than the 13.7% weight loss that users of Wegovy experienced. But despite these results, tech ...